Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1995
08/02/1995EP0664803A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders
08/02/1995EP0664802A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
08/02/1995EP0664801A1 Amide derivatives
08/02/1995EP0664800A1 Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
08/02/1995EP0664794A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
08/02/1995EP0664792A1 Fibrinogen receptor antagonists
08/02/1995EP0664789A1 Inhibitors of farnesyl protein transferase
08/02/1995EP0664788A1 Substituted ethanolamine esters
08/02/1995EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
08/02/1995EP0664779A1 Antibiotic agents
08/02/1995EP0664709A1 Pharmaceutical composition containing an antimicrobial agent and an antibiotic
08/02/1995EP0664708A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
08/02/1995EP0664707A1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma.
08/02/1995EP0664706A1 Protein kinase c inhibition and novel compound balanol
08/02/1995EP0664705A1 Use of ergoline derivatives for the treatment of glaucoma
08/02/1995EP0664704A1 Use of dopamine agonists to activate gamma-interferon production
08/02/1995EP0664702A1 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies
08/02/1995EP0664700A1 Treatment of cachexia and inhibition of il-6 activity
08/02/1995EP0664697A1 Ranitidine chewable tablets
08/02/1995EP0664696A1 Sustained release compositions for treating periodontal disease.
08/02/1995EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
08/02/1995EP0569482B1 Synthesis of intermediates in the preparation of acat inhibitors
08/02/1995EP0550615B1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier
08/02/1995EP0544765B1 Piperazinyl derivatives with affinity for 5-HT receptors
08/02/1995EP0522030B1 Hepatitis b vaccine
08/02/1995EP0506774B1 Smoking substitute
08/02/1995EP0386232B1 Nasal administration of benzodiazepine hypnotics
08/02/1995CN1106067A Enzymatic hydroxylation process for the preparation HMG-COA reductase inhibitors and intermediates thereof
08/02/1995CN1106065A Maltose-trehalose converting enzyme, and preparation and uses thereof
08/02/1995CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions
08/02/1995CN1106016A Process of preparing etoposide phosphate and etoposide
08/02/1995CN1106014A PyridoÛ1,2,3-D,EÙÛ1,3,4Ùbenzoxadiazine derivatives
08/02/1995CN1106013A Therapeutic or preventive agents for diseases associated with peroxyli peroxylipid
08/02/1995CN1106009A Preparation of imidazopyridine derivative
08/02/1995CN1106008A 4-aryloxy-and 4-arylthiopiperidine derivatives
08/02/1995CN1106007A Novel sulfonylamino pyrimidines
08/02/1995CN1106006A Crystals of antimicrobial compound
08/02/1995CN1106005A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives
08/02/1995CN1106004A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
08/02/1995CN1106003A Inhibitors of microsomal triglyceride transfer protein and method
08/02/1995CN1106001A Lactol derivatives, their production and use
08/02/1995CN1105999A Analgesic compounds, their preparation and their use
08/02/1995CN1105998A Naphthoxazines
08/02/1995CN1105996A Preparation of imidazopyridine derivative
08/02/1995CN1105995A Crystal modification of (4-cyclopropyl-6-methyl-pyrimidin-2-yl)-phenyl-amine
08/02/1995CN1105993A Preparation of sustituted azole
08/02/1995CN1105991A Quinoline compounds
08/02/1995CN1105990A Phenylalkanolamine derivatives
08/02/1995CN1105989A Tricyclic 1-aminoethylpyrrol derivative
08/02/1995CN1105988A 1-amino-ethylindole-derivatives
08/02/1995CN1105984A Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
08/02/1995CN1105981A 芳香羧酸衍生物 Aromatic carboxylic acid derivatives
08/02/1995CN1105967A Stilbene derivatives and carcinostatics containing them
08/02/1995CN1105882A Parathyroid hormone and raloxifene for increasing bone mass
08/02/1995CN1105867A High-efficacy compound drug for treatment of rheumatism
08/02/1995CN1105859A Stable liquid preparation of complex vitamin for internal use
08/02/1995CN1105858A Pyrimidones and imidazolinones for treatment of shock
08/02/1995CN1105857A Aqueous agent
08/02/1995CN1105856A Smoking suppressant and method of application thereof
08/02/1995CN1105855A Formulation comprising antibacterial substance and antiulcer substance
08/02/1995CN1105854A Use of benzenesulphonylindole derivatives for the preparation of medicines
08/02/1995CN1105853A Methods for inhibiting bone loss
08/02/1995CN1105852A Endermic nutrient material and cosmetic composition containing the same
08/02/1995CN1029405C Lipid A analogs having immunoactivating and antitumor activity
08/02/1995CN1029404C Process for preparation of alpha-adrenergic receptor antagonists
08/02/1995CN1029403C 2-oxo-1-oxa-8-azaspiro|4,5¨ decane derivatives, pharmaceutical compositions containing them and process for preparing-same
08/02/1995CN1029400C Side chain homologe vitamin-D-derivatives, process for preparing same, pharmaceutical preparation containing same and use as medicine
08/02/1995CA2141367A1 Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compounds
08/02/1995CA2141366A1 Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds
08/02/1995CA2141350A1 Novel kojic acid derivatives
08/01/1995US5438151 Reacting N-alpha, N-alpha dimethylated histidine ester salt with halogenothionoformate in presence of base to obtain sulfur containing substituent, protecting, reacting with alkylating agent, freeing by saponification or hydrolysis
08/01/1995US5438144 Controlling damage to peripheral nerves
08/01/1995US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists
08/01/1995US5438136 Benzo-fused macrocycles promote release of growth hormone
08/01/1995US5438134 Process for the production of unsaturated 17 α-cyanomethyl-17 β-h
08/01/1995US5438118 Peptide mimics having constrained peptide backbone
08/01/1995US5438075 Oral glutamine to reduce stomatitis
08/01/1995US5438074 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
08/01/1995US5438073 Dermatological and/or cosmetological composition containing retinoids
08/01/1995US5438072 Taxoid-based compositions
08/01/1995US5438071 Stable porfimer sodium compositions and methods for their manufacture
08/01/1995US5438069 1,2-dideoxy-2-(hydroxymethyl)-1-(methylamino)-myo-inositol hydrochloride and stereoisomers; for treatment of viral infections and metastatic tumors
08/01/1995US5438068 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
08/01/1995US5438067 Medetomidine preparations for transdermal administration
08/01/1995US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders
08/01/1995US5438060 Method of reducing elevated intraocular pressure
08/01/1995US5438058 Composition intended to be used for retarding hair loss and for inducing and stimulating hair growth, containing 2-alkyl-4-aminopyrimidine (or 2,4-dialkylpyrimidine) 3-oxide derivatives and new compounds derived from 2-alkyl-4-aminopyrimidine 3-oxide
08/01/1995US5438057 Administering a 1,2-bis(3,5-dioxo-4-piperazin-1-yl cyclobutane or-propane for cardioprotection particularly in conjunction with adriamycins
08/01/1995US5438055 Antiarrhythmic benzodiazepines
08/01/1995US5438052 Cephalosporin derivatives
08/01/1995US5438049 16-epiestriol to prevent, inhibit, or reduce inflammation without glycogenic effects
08/01/1995US5438048 Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation
08/01/1995US5437874 Pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredients
08/01/1995US5437873 Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
08/01/1995US5437272 Supplying respiratory gas under positive pressure; maintaining respiratory gas exchange in perfluorocarbon liquid-filled pulmonary air passages
08/01/1995CA2141231A1 6-azaindole thromboxane synthase inhibitors
08/01/1995CA2140953A1 Polyhydronorharman synthase inhibitors
08/01/1995CA2020812C Liquid suspensions of nitrofurantoin
08/01/1995CA2018477C Process for preparing 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic, acid monosodium salt trihydrate
08/01/1995CA2000911C Aqueous extract from pittosporaceae effective for diabetes and liver complaints and process for preparing the same